(BETHESDA, Md.)Biotechnology company Micromet Inc. said Tuesday it will sell $40 million in stock to fund development of its lead drug candidate, an antibody designed to treat cancer.READ MORE
(BETHESDA, Md.)Drug developer Micromet Inc. said Wednesday that Barclay A. "Buck" Phillips had been appointed senior vice president and chief financial officer. Phillips has been a member of Micr...READ MORE